Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Celina Ledesma"'
Autor:
Oren Pasvolsky, Rima M. Saliba, Celina Ledesma, Uday R. Popat, Amin Alousi, Amanda Olson, Betul Oran, Chitra Hosing, Qaiser Bashir, Muzaffar H. Qazilbash, Nicholas J. Short, Farhad Ravandi, Richard Champlin, Elizabeth J. Shpall, Partow Kebriaei
Publikováno v:
American Journal of Hematology. 98
Autor:
Alejandro Marinos, Jeremy L Ramdial, Rima M. Saliba, Fareed Khawaja, Amin M. Alousi, Gabriela Rondon, Julianne Chen, Celina Ledesma, Dr. Roy F. Chemaly, Richard E. Champlin, David Marin, May Daher, Katayoun Rezvani, Elizabeth J. Shpall
Publikováno v:
Transplantation and Cellular Therapy. 29:S339-S340
Autor:
David Marin, Elias Jabbour, Denái R. Milton, Amanda Olson, Gabriela Rondon, Jin S. Im, Rohtesh S. Mehta, Uday R. Popat, May Daher, Felipe Samaniego, Loretta J. Nastoupil, Neeraj Saini, Celina Ledesma, Paolo Anderlini, Muzaffar H. Qazilbash, Qaiser Bashir, Issa F. Khouri, Alison M. Gulbis, Richard E. Champlin, L. Jeffrey Medeiros, Swaminathan P. Iyer
Publikováno v:
Clinical Cancer Research. 27:5847-5856
Purpose: To compare outcomes between patients with relapsed follicular lymphoma who received a nonmyeloablative allogeneic stem cell transplant (alloSCT) and those who received an autologous transplant (autoSCT). Patients and Methods: We evaluated 19
Autor:
Oren Pasvolsky, Rima M. Saliba, Celina Ledesma, Uday R Popat, Amin M Alousi, Amanda L. Olson, Betul Oran, Chitra Hosing, Qaiser Bashir, Muzaffar H Qazilbash, Nicholas Short, Farhad Ravandi, Richard E Champlin, Elizabeth J Shpall, Partow Kebriaei
Publikováno v:
Blood. 140:7695-7696
Autor:
Yago Nieto, Benigno C Valdez, Peter F Thall, Jeremy L. Ramdial, Samer A Srour, Chitra Hosing, Neeraj Saini, Amin M Alousi, Muzaffar H Qazilbash, Uday R Popat, Alison Gulbis, Terri Lynn Shigle, Roland Bassett, Maria Guillermo-Pacheco, Celina Ledesma, Paolo Strati, Sairah Ahmed, Raphael Steiner, Jason Westin, Ranjit Nair, Swaminathan P. Iyer, Richard E Champlin, Elizabeth J Shpall, Borje S Andersson
Publikováno v:
Blood. 140:1183-1184
Autor:
Rohtesh S. Mehta, Issa F. Khouri, Paul Koller, Muzaffar H. Qazilbash, Partow Kebriaei, Elias Jabbour, Betul Oran, Chitra Hosing, Jeffrey L. Jorgensen, Stefan O. Ciurea, Marina Konopleva, Richard E. Champlin, Elizabeth J. Shpall, Nitin Jain, Amanda Olson, Hagop M. Kantarjian, Uday R. Popat, Sa Wang, Gabriela Rondon, Celina Ledesma, Rima M. Saliba, Amin M. Alousi
Publikováno v:
Bone Marrow Transplantation. 56:1746-1749
Autor:
Stefan O. Ciurea, Elias Jabbour, Amin M. Alousi, Uday R. Popat, Ruby Delgado, Chitra Hosing, Elizabeth J. Shpall, Muzaffar H. Qazilbash, Yago Nieto, David Marin, Celina Ledesma, Qaiser Bashir, Issa F. Khouri, Farhad Ravandi, Neeraj Saini, Hagop M. Kantarjian, Partow Kebriaei, Richard E. Champlin, Gabriela Rondon
Publikováno v:
Blood. 136:1786-1789
How to best use tyrosine kinase inhibitors (TKIs) of BCR-ABL after allogeneic stem cell transplantation for Philadelphia chromosome–positive acute lymphoblastic leukemia (ALL) is unknown but will almost certainly not be addressed by a definitive ra
Autor:
Celina Ledesma, Gabriela Rondon, Ankur Varma, Rima M. Saliba, Stefan O. Ciurea, Richard E. Champlin, Julianne Chen, Samer A. Srour
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:1013-1020
Fluid overload (FO) grade ≥2 (more than 10% weight gain from baseline) has recently been recognized as an important toxicity associated with a high rate of nonrelapse mortality in recipients of allogeneic hematopoietic cell transplantation (AHCT).
Autor:
Celina Ledesma, Samer A. Srour, Partow Kebriaei, Alison M. Gulbis, Ranjit Nair, Paolo Anderlini, Jin S. Im, Hagop M. Kantarjian, Nitin Jain, Felipe Samaniego, Stephen K. Gruschkus, Richard E. Champlin, Paolo Strati, Elias Jabbour, May Daher, Neeraj Saini, Loretta J. Nastoupil, Gabriela Rondon, Luis Fayad, Tapan M. Kadia, Qaiser Bashir, Christopher R. Flowers, Uday R. Popat, Swaminathan P. Iyer, Rohtesh S. Mehta, Naveen Pemmaraju, Issa F. Khouri, David Marin
Publikováno v:
Blood. 136:10-12
Background: Inotuzumab Ozogamicin (INO) is a humanized anti-CD22 monoclonal antibody that has emerged as an attractive therapeutic target for CD22+ b-cell lymphoid malignancies. We prospectively studied the safety and efficacy of INO when added to ou
Autor:
Issa F. Khouri, Jin S. Im, Loretta J. Nastoupil, Swami P. Iyer, Felipe Samaniego, Qaiser Bashir, Christopher R. Flowers, Padmanee Sharma, Hun Ju Lee, Elias Jabbour, Denái R. Milton, Richard E. Champlin, Luis Fayad, Ranjit Nair, Alison M. Gulbis, Celina Ledesma
Publikováno v:
Blood. 136:9-11
Background: Relapse is the major cause of failure after autologous stem cell transplantation (autoSCT) for patients (pts) with lymphoma. Targeting immune checkpoints with ipilimumab (Ipi) could result in lasting responses but only in few pts. We have